ID   NCC-DDLPS6-C1
AC   CVCL_C1GH
DR   Wikidata; Q114312458
RX   PubMed=35604485;
WW   Provider; BizCom; -; https://en.cellline.jp/product/ncc-ddlps6-c1/
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 47 hours (PubMed=35604485).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Right leg; UBERON=UBERON_0000978.
ST   Source(s): PubMed=35604485
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 9,13
ST   D21S11: 31.2,32.2
ST   D5S818: 11,13
ST   D7S820: 10,13
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
RX   PubMed=35604485; DOI=10.1007/s13577-022-00710-8;
RA   Yoshimatsu Y., Noguchi R., Sin Y., Tsuchiya R., Ono T., Akiyama T.,
RA   Nakagawa R., Kamio S., Hirabayashi K., Ozawa I., Kikuta K., Kondo T.;
RT   "Establishment and characterization of a novel patient-derived cell
RT   line of dedifferentiated liposarcoma, NCC-DDLPS6-C1.";
RL   Hum. Cell 35:1270-1278(2022).
//